N-ACETYLATION POLYMORPHISM OF DAPSONE IN A JAPANESE POPULATION

被引:28
作者
HORAI, Y [1 ]
ISHIZAKI, T [1 ]
机构
[1] NATL MED CTR,CLIN RES INST,DIV CLIN PHARMACOL,TOYAMA 1-21-2,SHINJUKU KU,TOKYO,JAPAN
关键词
D O I
10.1111/j.1365-2125.1988.tb03333.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:487 / 494
页数:8
相关论文
共 30 条
[1]   PLASMA AND SALIVARY PHARMACOKINETICS OF DAPSONE ESTIMATED BY A THIN-LAYER CHROMATOGRAPHIC METHOD [J].
AHMAD, RA ;
ROGERS, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :129-133
[2]  
CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x
[3]  
CARTWRIGHT RA, 1982, LANCET, V2, P842
[4]   KINETIC DISCRIMINATION OF 3 SULFAMETHAZINE ACETYLATION PHENOTYPES [J].
CHAPRON, DJ ;
KRAMER, PA ;
MERCIK, SA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) :104-113
[5]   GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].
CLARK, DWJ .
DRUGS, 1985, 29 (04) :342-375
[6]  
DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251
[7]   SURVEY OF THE HUMAN ACETYLATOR POLYMORPHISM IN SPONTANEOUS DISORDERS [J].
EVANS, DAP .
JOURNAL OF MEDICAL GENETICS, 1984, 21 (04) :243-253
[8]  
EVANS DAP, 1960, BRIT MED J, V2, P458
[9]  
EVANS DAP, 1986, ETHNIC DIFFERENCES R, P209
[10]  
GELBER R, 1971, CLIN PHARMACOL THER, V12, P225